News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
78,448 Results
Type
Article (1015)
Company Profile (12)
Press Release (77421)
Section
Business (21298)
Career Advice (129)
Deals (8330)
Drug Delivery (1)
Drug Development (6743)
Employer Resources (2)
FDA (1325)
Job Trends (1568)
News (38206)
Policy (2772)
Tag
Academia (88)
Accelerated approval (3)
Allergies (2)
Alliances (5946)
ALS (13)
Alzheimer's disease (173)
Antibody-drug conjugate (ADC) (19)
Approvals (1383)
Artificial intelligence (27)
Autoimmune disease (7)
Automation (3)
Bankruptcy (85)
Best Places to Work (1393)
Biosimilars (29)
Biotechnology (9)
Bladder cancer (9)
Brain cancer (11)
Breast cancer (53)
Cancer (478)
Cardiovascular disease (23)
Career advice (110)
CAR-T (20)
Celiac Disease (1)
Cell therapy (56)
Cervical cancer (3)
Clinical research (6072)
Collaboration (121)
Compensation (58)
Complete response letters (4)
COVID-19 (104)
CRISPR (1)
C-suite (73)
Cystic fibrosis (11)
Data (616)
Depression (11)
Diabetes (31)
Diagnostics (730)
Digital health (5)
Diversity, equity & inclusion (1)
Drug discovery (17)
Drug pricing (5)
Duchenne muscular dystrophy (12)
Earnings (7873)
Editorial (1)
Employer branding (1)
Employer resources (2)
Events (10831)
Executive appointments (129)
FDA (1622)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (164)
Gene editing (6)
Gene therapy (11)
GLP-1 (29)
Government (194)
Guidances (46)
Healthcare (2006)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (10)
Immuno-oncology (7)
Indications (10)
Infectious disease (119)
Inflammatory bowel disease (28)
Influenza (9)
Intellectual property (42)
Interviews (23)
IPO (4927)
Job creations (209)
Job search strategy (93)
JPM (2)
Labor market (1)
Layoffs (14)
Legal (906)
Liver cancer (4)
Lung cancer (64)
Lymphoma (26)
Machine learning (2)
Manufacturing (46)
MASH (13)
Medical device (1864)
Medtech (1869)
Mergers & acquisitions (3846)
Metabolic disorders (73)
Multiple sclerosis (9)
NASH (1)
Neurodegenerative disease (25)
Neuropsychiatric disorders (7)
Neuroscience (298)
Neurotech (1)
NextGen: Class of 2026 (907)
Non-profit (167)
Obesity (30)
Opinion (3)
Ovarian cancer (18)
Pain (22)
Pancreatic cancer (49)
Parkinson's disease (39)
Partnered (3)
Patents (80)
Patient recruitment (41)
Peanut (2)
People (6755)
Pharmacy benefit managers (3)
Phase 1 (1890)
Phase 2 (2816)
Phase 3 (1969)
Pipeline (570)
Policy (2)
Postmarket research (146)
Preclinical (733)
Press Release (1)
Prostate cancer (19)
Psychedelics (2)
Radiopharmaceuticals (48)
Rare diseases (57)
Real estate (529)
Recruiting (1)
Regulatory (2066)
Reports (6)
Research institute (141)
Resumes & cover letters (15)
RSV (6)
Schizophrenia (35)
Series A (21)
Series B (19)
Sickle cell disease (17)
Special edition (1)
Spinal muscular atrophy (3)
Startups (499)
State (1)
Stomach cancer (1)
Supply chain (8)
Vaccines (37)
Venture capital (1)
Weight loss (5)
Women's health (5)
Date
Last 7 days (62)
Last 30 days (209)
Last 365 days (3490)
2026 (297)
2025 (3551)
2024 (4457)
2023 (5506)
2022 (6728)
2021 (7861)
2020 (7576)
2019 (5284)
2018 (4090)
2017 (3925)
2016 (3234)
2015 (4529)
2014 (3095)
2013 (2533)
2012 (2710)
2011 (2362)
2010 (2113)
Location
Africa (22)
Alabama (6)
Arizona (44)
Arkansas (1)
Asia (3803)
Australia (504)
California (1393)
Canada (231)
China (64)
Colorado (41)
Connecticut (81)
Delaware (30)
Europe (5547)
Florida (278)
Georgia (37)
Idaho (7)
Illinois (99)
India (2)
Indiana (85)
Japan (25)
Kansas (19)
Kentucky (7)
Louisiana (3)
Maine (45)
Maryland (177)
Massachusetts (841)
Michigan (72)
Minnesota (76)
Mississippi (4)
Missouri (19)
Montana (2)
Nebraska (4)
Nevada (38)
New Hampshire (14)
New Jersey (432)
New Mexico (2)
New York (442)
North Carolina (284)
Northern California (558)
Ohio (41)
Oregon (3)
Pennsylvania (346)
Rhode Island (4)
South America (65)
South Carolina (11)
Southern California (624)
Tennessee (45)
Texas (376)
United States (5411)
Utah (62)
Vermont (1)
Virginia (46)
Washington D.C. (2)
Washington State (89)
West Virginia (1)
Wisconsin (23)
78,448 Results for "alector llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Neuropsychiatric disorders
Alector Scraps Dementia Drug After Phase III Flop, Lays Off 49% of Staff
This represents Alector’s second failed neurodegenerative asset in a year, after an AbbVie-partnered asset missed in Alzheimer’s last November. On latozinemab for frontotemporal dementia, Alector was working with GSK, which fronted $700 million in 2021 to collaborate on two programs.
October 22, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Alector Cuts Staff Again, This Time Laying Off 13% of Workforce
As part of cost-cutting efforts, Alector is letting go of about 25 people as it focuses on advancing its preclinical and research pipeline. Alector is also continuing clinical-stage work on programs for frontotemporal dementia and Alzheimer’s disease.
March 25, 2025
·
2 min read
·
Angela Gabriel
Alzheimer’s disease
Alector’s AbbVie-Partnered Alzheimer’s Program Fails Phase II, Triggering a 17% Layoff
Alector is kicking off a resource realignment effort that will include a workforce reduction. The biotech expects its current cash position to last it through 2026.
November 26, 2024
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Sanofi Buys Vigil for $470M Upfront, Reigniting a Battered Alzheimer’s Target
The deal helps revitalize the TREM2 target after the high-profile failure of AbbVie and Alector’s candidate last year.
May 22, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer
December 17, 2025
·
3 min read
Press Releases
Kathy Spencer-Pike Joins NorthStar Medical Radioisotopes, LLC as Chief Commercial Officer
December 17, 2025
·
3 min read
Press Releases
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
January 16, 2026
·
3 min read
Press Releases
Curonix LLC Announces Commercial Availability of the Freedom® Peripheral Nerve Stimulator (PNS) System as the Only Full-Body PNS Therapy Available in the United States for Craniofacial Pain
January 19, 2026
·
3 min read
Press Releases
CellRight Technologies, LLC Announces Update and Senior Leadership Changes
October 21, 2025
·
3 min read
Press Releases
NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor
December 17, 2025
·
3 min read
1 of 7,845
Next
